Survival of children with chronic myeloid leukemia.

Chronic myeloid leukemia and chronic lymphocytic leukemia.

Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia.

Treatment of chronic phase chronic myeloid leukemia with imatinib.

Complete cytogenetic response, not deep molecular response, is associated with survival in chronic myeloid leukemia.

Bosutinib for Chronic Myeloid Leukemia.

Chronic myeloid leukemia in India.

Splenectomy in chronic myeloid leukemia.

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.

Letter: Survival in acute myeloid leukemia.

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).

Massive splenic infarction and portal vein thrombosis in children with chronic myeloid leukemia.

Managing children with chronic myeloid leukaemia.

Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.

Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.

Immunology and immunotherapy of chronic myeloid leukemia.

Current management of chronic myeloid leukemia with tyrosine kinase inhibitors.

Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.

Leukemia stem cells: the root of chronic myeloid leukemia.

Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival.

ABCB1 gene polymorphisms in patients with chronic myeloid leukemia.

Pyoderma gangrenosum in a patient with chronic myeloid leukemia.

Chronic myeloid leukemia: room for improvement?

Initial treatment for patients with chronic myeloid leukemia.

VEGF in chronic myeloid leukemia treated with interferon and imatinib.

Suggest Documents

Chronic myeloid leukemia and chronic lymphocytic leukemia.

Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia.

Treatment of chronic phase chronic myeloid leukemia with imatinib.

Complete cytogenetic response, not deep molecular response, is associated with survival in chronic myeloid leukemia.

Bosutinib for Chronic Myeloid Leukemia.

Chronic myeloid leukemia in India.

Splenectomy in chronic myeloid leukemia.

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.

Letter: Survival in acute myeloid leukemia.

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).

Massive splenic infarction and portal vein thrombosis in children with chronic myeloid leukemia.

Managing children with chronic myeloid leukaemia.

Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.

Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.

Immunology and immunotherapy of chronic myeloid leukemia.

Current management of chronic myeloid leukemia with tyrosine kinase inhibitors.

Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.

Leukemia stem cells: the root of chronic myeloid leukemia.

Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival.

ABCB1 gene polymorphisms in patients with chronic myeloid leukemia.

Pyoderma gangrenosum in a patient with chronic myeloid leukemia.

Chronic myeloid leukemia: room for improvement?

Initial treatment for patients with chronic myeloid leukemia.

VEGF in chronic myeloid leukemia treated with interferon and imatinib.

Survival of children with chronic myeloid leukemia.

Recommend Documents

Follow Us